FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
WEIL JOHN D
(Last) (First) (Middle)
4625 LINDELL BLVD., #335
(Street)
ST. LOUIS MO 63108
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC [ AHPI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/26/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/26/2021   S   69,249 D $ 8.437 (1) 25,178 (2) I Spouse
Common Stock 11/26/2021   S   59,101 D $ 8.467 (1) 0 (3) I Trust
Common Stock 11/26/2021   S   7,514 D $ 8.0565 (1) 0 (4) I Corporation
Common Stock               53,810 (5) I Trust
Common Stock               90,513 D  
Common Stock               2,500 I IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock $ 5.09 11/11/2021 11/11/2021 A   750   11/11/2022 11/11/2031 Common stock 750 (6) $ 0 750 D  
Option to purchase common stock $ 5.18             11/08/2013 11/08/2022 Common stock 750   750 D  
Option to purchase common stock $ 4.62             11/14/2014 11/14/2023 Common stock 750   750 D  
Option to purchase common stock $ 3.16             11/13/2015 11/13/2024 Common stock 750   750 D  
Option to purchase common stock $ 2.34             11/12/2016 11/12/2025 Common stock 750   750 D  
Option to purchase common stock $ 2.26             11/10/2017 11/10/2026 Common stock 750   750 D  
Option to purchase common stock $ 2.22             11/09/2018 11/09/2027 Common stock 750   750 D  
Option to purchase common stock $ 2.13             11/08/2019 11/08/2028 Common stock 750   750 D  
Option to purchase common stock $ 1.17             11/07/2020 11/07/2029 Common stock 750   750 D  
Option to purchase common stock $ 7.86             11/12/2021 11/12/2030 Common stock 750   750 D  
Explanation of Responses:
1. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The reporting person disclaims any economic benefit in such shares.
3. Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
4. Owned by a corporation controlled by the reporting person.
5. Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. The decrease of 6,710 reported shares between the amount reported in this filing and the amount reported in the most recent previous filing is due to omission of a trust for which the reporting person no longer serves as trustee and with respect to which the reporting person no longer has any pecuniary interest.
6. Issued pursuant to the Company's 2013 Director's Stock Option Plan.
/s/ John D. Weil 11/30/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.